BioSpace News Archive

Job Trends

Clovis Oncology Announces Proposed Offerings of Convertible Senior Notes and Common Stock

Clovis intends to offer, subject to market and other conditions, $200 million aggregate principal amount of its convertible senior notes due 2025 in an underwritten registered public offering.

April 16, 2018
·
5 min read
Drug Development

Preclinical Data Presented at AACR 2018 Shows Esperance Pharmaceuticals’ EP-100 Is Synergistic with PARP Inhibitor Olaparib in Ovarian Cancer

Studies Conducted by MD Anderson Cancer Center Elucidate the Mechanisms by Which EP-100 Kills Ovarian Cancer Cells on Its Own and Synergistically in Combination with a Leading PARP Inhibitor

April 16, 2018
·
5 min read
FDA

Roche receives FDA clearance for cobas® CT/NG for cobas® 6800/8800 Systems

First moderate complexity molecular test for sexually transmitted infections on fully automated, high throughput platform

April 16, 2018
·
5 min read
FDA

Alkermes Announces FDA Acceptance for Review of New Drug Application for ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder

FDA’s target action date for the ALKS 5461 NDA is Jan. 31, 2019.

April 16, 2018
·
6 min read
FDA

Exemplar Genetics Rare Neurological Disease Model Cleared by FDA for Commercial Research Use

FDA has exercised enforcement discretion in regard to the ExeGen®ATM MiniSwine model clearing it for commercial use as a research model.

April 16, 2018
·
4 min read